JAAD 09/26 Wound Care – Part II: Tissue-engineered skin substitutes & other advanced wound therapies

JAAD 09/26 Wound Care – Part I: A practical approach to local wound care and dressing selection

Wound care is a core dermatologic skill, yet training rarely covers it in depth. This CME activity covers clinical wound assessment and traditional dressing selection (Part I), then tissue-engineered skin substitutes and cellular, acellular, and matrix-like products (Part II). Build a practical framework for matching wound characteristics to the right dressing or biologic therapy.

1 CME

JAAD 08/26 Diagnosis and management of cutaneous infections in immunocompromised hosts part I: cellular immunodeficiency

Immunocompromised patients face distinct infection risks depending on which arm of immunity is impaired. This CME activity covers opportunistic infections in cellular immunodeficiency (mycobacteria, systemic mycoses, protozoa) and in neutropenia and humoral immunodeficiency (ecthyma gangrenosum, opportunistic mycoses, herpesviruses, Neisseria). Sharpen the ability to match cutaneous findings to the underlying immune defect and choose the right diagnostic and treatment approach.

1 CME

JAAD 08/26 Diagnosis and management of cutaneous infections in immunocompromised hosts part II: neutropenia and humoral immunodeficiency

Immunocompromised patients face distinct infection risks depending on which arm of immunity is impaired. This CME activity covers opportunistic infections in cellular immunodeficiency (mycobacteria, systemic mycoses, protozoa) and in neutropenia and humoral immunodeficiency (ecthyma gangrenosum, opportunistic mycoses, herpesviruses, Neisseria). Sharpen the ability to match cutaneous findings to the underlying immune defect and choose the right diagnostic and treatment approach.

1 CME

JAAD 07/26 Minimally-invasive modalities for non-melanoma skin cancer Part II: Treatment

Keratinocyte carcinoma is the most common cancer in the US, yet biopsy and surgery are not always feasible or desired. This CME activity covers noninvasive diagnostic tools, including dermoscopy, confocal microscopy, and optical coherence tomography, then reviews evidence-based treatment alternatives, from topical and intralesional therapies to photodynamic therapy, for patients who are poor surgical candidates. Build a practical toolkit for diagnosing and managing keratinocyte carcinoma when surgery isn't the first choice.

1 CME

JAAD 07/26 Minimally invasive modalities for keratinocyte carcinomas Part I: Diagnostics

Keratinocyte carcinoma is the most common cancer in the US, yet biopsy and surgery are not always feasible or desired. This CME activity covers noninvasive diagnostic tools, including dermoscopy, confocal microscopy, and optical coherence tomography, then reviews evidence-based treatment alternatives, from topical and intralesional therapies to photodynamic therapy, for patients who are poor surgical candidates. Build a practical toolkit for diagnosing and managing keratinocyte carcinoma when surgery isn't the first choice.

1 CME

JAAD 12/25 Lentigo Maligna Part I: Epidemiology, Risk Factors, and Diagnosis

Multiple Credits

JAAD 04/26 Frontal Fibrosing Alopecia (FFA) Part I - Diagnosis and Clinical Presentation

Frontal fibrosing alopecia is on the rise, and its slow, scarring progression makes early recognition critical. This CME activity covers the demographics, clinical subtypes, and trichoscopy findings that define FFA, then digs into its proposed etiopathogenesis and the treatment strategies used to stabilize disease progression. Sharpen your ability to recognize and manage this increasingly common cause of scarring hair loss.

1 CME

JAAD 12/25 Lentigo Maligna Part II: Management

Multiple Credits

JAAD 06/26 Photodynamic Therapy: Overview and Mechanism of Action

Photodynamic therapy (PDT) has expanded well beyond actinic keratoses, with growing evidence across many dermatologic conditions. This CME activity covers PDT's mechanism of action, photosensitizers, and light sources, then reviews its evidence-based clinical applications, from actinic keratoses and basal cell carcinoma to acne, port wine stains, and rosacea. Build a practical, evidence-based framework for incorporating PDT into dermatologic practice.

1 CME

JAAD 02/26 Acral Lentiginous Melanoma. Part I. Epidemiology, Etiology, Molecular Profile, Clinical Presentation, and Diagnosis

Acral lentiginous melanoma is rare, easy to overlook, and disproportionately deadly for patients of color. This CME activity explores the epidemiology, molecular landscape, and diagnostic clues that set ALM apart from other melanomas, then moves into staging, surgical management, and the systemic therapies shaping outcomes in advanced disease. Build the clinical instincts to catch ALM earlier and manage it more effectively.

1 CME